News
8h
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.
Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus ...
8h
Zacks.com on MSNBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
The payoff in lives and hospital time saved runs at about 100 to 1 per dollar invested, which is a great deal by any standard ...
TORONTO, Aug. 22, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with ...
New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
In the wake of funding cuts to mRNA vaccine research, we revisit a February story about a promising vaccine for pancreatic ...
15h
inews.co.uk on MSNThe new vaccines and treatments that could stop cancer in its tracks
The immune system’s role is usually seen as wiping out invading pathogens like bacteria and viruses, but several types of ...
The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...
The American College of Obstetricians and Gynecologists on Friday said it continues to recommend the use of COVID-19 vaccines during pregnancy, becoming the latest physician group to diverge from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results